NeuroVigil Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

NeuroVigil General Information

Description

Operator of a neurotechnology development company intended to monitor and generate readings and automated readings of brain wave data. The company utilizes non-invasive wireless brain recording technology and advanced computational algorithms to develop proprietary brain monitors and sophisticated machine learning algorithms that detect a constellation of biomarkers of pathologies in asymptomatic individuals, enabling pharmaceutical companies to utilize EEG recordings to analyze drug efficacy and screen for biomarker data indicating neuropathologies.

Contact Information

Website
www.neurovigil.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • NASA Research Park
  • PO Box 111 Moffett Field
  • Mountain View, CA 94035-0111
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Other Healthcare Technology Systems
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, HealthTech, Oncology
Corporate Office
  • NASA Research Park
  • PO Box 111 Moffett Field
  • Mountain View, CA 94035-0111
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroVigil Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 01-Jan-2025 Completed Generating Revenue
6. Later Stage VC 07-Jul-2021 Completed Generating Revenue
5. Secondary Transaction - Private Completed Generating Revenue
4. Later Stage VC (Series A) 03-May-2015 Completed Generating Revenue
3. Seed Round 01-Jan-2011 Completed Startup
2. Grant 02-Jul-2008 $30K Completed Startup
1. University Spin-Out 05-Feb-2007 Completed Startup
To view NeuroVigil’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

NeuroVigil Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a neurotechnology development company intended to monitor and generate readings and automated readings of br
Diagnostic Equipment
Mountain View, CA

San Francisco, CA
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NeuroVigil Competitors (9)

One of NeuroVigil’s 9 competitors is EMOTIV, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EMOTIV Venture Capital-Backed San Francisco, CA
Muse (Monitoring Equipment) Venture Capital-Backed Toronto, Canada
AliveCor Venture Capital-Backed Mountain View, CA
NeuroSky Formerly VC-backed San Jose, CA
Kinetic River Corporation Mountain View, CA
You’re viewing 5 of 9 competitors. Get the full list »

NeuroVigil Patents

  • 92

    Total Documents Applications and Grants

  • Total Patents Families

  • 30

    Granted

  • 37

    Pending

  • Expiring in next 12 mo

NeuroVigil Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260188497-A1 Detection of autism spectrum disorder using physiological signals Pending 30-Dec-2024
WO-2026147905-A1 Detection of autism spectrum disorder using physiological signals Pending 30-Dec-2024
US-20260189386-A1 Encryption method utilizing infinite grid for prime identification Pending 30-Dec-2024
WO-2026147907-A1 Encryption method utilizing infinite grid for prime identification Pending 30-Dec-2024
US-20260342565-A1 Cryptography systems and methods utilizing "low conjecture" for prime identification Pending 28-Dec-2023 H04L9/3033
To view NeuroVigil’s complete patent history, request access »

NeuroVigil Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
2b AHEAD Ventures Venture Capital Minority
Draper Associates Venture Capital Minority
Massachusetts Institute of Technology University
Salk Institute University
To view NeuroVigil’s complete investors history, request access »

Ready to get started?

Request a free trial

NeuroVigil FAQs

  • When was NeuroVigil founded?

    NeuroVigil was founded in 2007.

  • Where is NeuroVigil headquartered?

    NeuroVigil is headquartered in Mountain View, CA.

  • What industry is NeuroVigil in?

    NeuroVigil’s primary industry is Diagnostic Equipment.

  • Is NeuroVigil a private or public company?

    NeuroVigil is a Private company.

  • What is NeuroVigil’s current revenue?

    The current revenue for NeuroVigil is .

  • How much funding has NeuroVigil raised over time?

    NeuroVigil has raised $250K.

  • Who are NeuroVigil’s investors?

    2b AHEAD Ventures, Draper Associates, Massachusetts Institute of Technology, and Salk Institute have invested in NeuroVigil.

  • Who are NeuroVigil’s competitors?

    EMOTIV, Muse (Monitoring Equipment), AliveCor, NeuroSky, and Kinetic River are some of the 9 competitors of NeuroVigil.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process